Q32 Bio QTTB
NASDAQ QTTB
$8.80 +0.13 (+1.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Q32 Bio (QTTB) Equity Income (2024)

Updated

Q32 Bio (QTTB) recorded Equity Income of -$1.63 million in FY2024.

Analysis

Q32 Bio (QTTB) Equity Income (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -10.00 Mn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Q32 Bio 172.20 Mn -102.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.45 Mn
Mar 31, 2024 -176,000.00
API Access

Q32 Bio Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=QTTB&period=max&api_key=YOUR_API_KEY